Indo US Bio-Tech

Indo_US_Bio-Tech26 Apr 2024

Miscellaneous

₹

+18.95 (+8.77%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Indo US Bio-Tech

Indo US Bio-Tech

Miscellaneous

Indo_US_Bio-Tech26 Apr 2024

₹

+18.95 (+8.77%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
09-Oct-2021	D	This is to inform you that, the Board of Directors at their Meeting held on today i.e., 9th October, 2021 at 2:00 P.M. at the registered office of the Company, had considered. Recommendation of declaration of Dividend Rs. 0.25 (2.5%)	28-Oct-2021
21-Aug-2023	B	1:1 Bonus Issue of Equity Shares Trading Members of the Exchange are hereby informed that, INDO US BIO-TECH LIMITED has fixed Record Date for the purpose of Bonus Issue of Equity Shares of the Company. The transactions in the Equity Shares of the Company would be on an Ex-Bonus basis with effect from the under mentioned date :- DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE INDO US BIO-TECH LIMITED (541304) RECORD DATE 29.08.2023 PURPOSE Issue of 1 (One) Bonus Equity Share of Rs.10/- each for every 1 (One) existing Equity Share of Rs.10/- each held. Ex-Bonus basis from Date & Sett. No. 29/08/2023 DR-602/2023-2024 Trading Members are requested to note the Change in the Market lot of INDO US BIO-TECH LIMITED (541304) pursuant to the Bonus Issue of Equity Shares as given below, which will be effective from Tuesday, August 29, 2023: Scrip Code 541304 Scrip Name INDO US BIO-TECH LIMITED Current Market Lot 500 Revised Market Lot 1000 (As Per BSE Notice Dated on 22.08.2023)	29-Aug-2023	1:1
03-Nov-2021	B	1:5 Bonus Issue of Equity Shares Trading Members of the Exchange are hereby informed that, Indo US Bio-Tech Limited has fixed the record date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date: DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Indo US Bio-Tech Limited (541304) RECORD DATE 30/11/2021 PURPOSE Issue of 01 (One) Bonus equity shares of Rs.10/- each for every 05 (Five) existing equity share of Rs.10/- each held. Ex-Bonus basis from Date & Sett. No. 29/11/2021 DR-165/2021-2022 Trading Members are requested to note the change in the market lot of Indo US Bio-Tech Limited (541304) pursuant to the Bonus Issue of equity shares as given below, which will be effective from Monday, November 29, 2021 (As Per BSE Notice Dated on 17.11.2021)	30-Nov-2021	1:5
10-Apr-2019	B	1:4 Bonus Issue of Equity Shares Trading Members of the Exchange are hereby informed that, Indo US Bio-Tech Limited has fixed the record date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date. DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Indo US Bio-Tech Limited (541304) RECORD DATE 24/04/2019 PURPOSE Issue of 1(One) Bonus equity share of Rs.10/- each for every 4 (Four) existing equity shares of Rs.10/- each held. Ex-Bonus basis from Date & Sett. No. 23/04/2019 DR-017/2019-2020 Trading Members are requested to note the change in the market lot of Indo US Bio-Tech Limited (541304) pursuant to the Bonus Issue of equity shares as given below, which will be effective from Tuesday, April 23, 2019: Current Market Lot 2000 Revised Market Lot 2500 (As Per BSE Notice Dated on 11.04.2019)	24-Apr-2019	1:4
25-Apr-2024	BC	Quarterly Results & Audited Results	02-May-2024
24-Jan-2024	BC	Re-appointment of Mrs. Ritaben Nileshbhai Kikani (DIN: 08367656) as an Independent Director of the Company for a second term of five (5) years , Approved Notice of Postal Ballot, The Board meeting co	01-Mar-2024
24-Jan-2024	BC	Approved Notice of Postal Ballot The copy of Notice of Postal Ballot will be submitted to exchange as soon as the same be dispatched to the Shareholders of the Company through email. Notice of	28-Feb-2024
06-Feb-2024	BC	Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve the Un-Audited Financial results of the Co	14-Feb-2024
24-Jan-2024	BC	Re-appointment of Ms. Priyanka Jagdishbhai Ajudia (DIN: 07941023) as an Executive Director of the Company for a further period of five (5) years , Re-appointment of Mrs. Ritaben Nileshbhai Kikani (DI	24-Jan-2024

No Rights has been declared by Indo_US_Bio-Tech

Book Closure

Record Date	Split Date	Purpose
02-May-2024	-	Quarterly Results & Audited Results
01-Mar-2024	-	Re-appointment of Mrs. Ritaben Nileshbhai Kikani (DIN: 08367656) as an Independent Director of the Company for a second term of five (5) years , Approved Notice of Postal Ballot, The Board meeting co
28-Feb-2024	01 Jan'1900	Approved Notice of Postal Ballot The copy of Notice of Postal Ballot will be submitted to exchange as soon as the same be dispatched to the Shareholders of the Company through email. Notice of
14-Feb-2024	-	Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve the Un-Audited Financial results of the Co
24-Jan-2024	-	Re-appointment of Ms. Priyanka Jagdishbhai Ajudia (DIN: 07941023) as an Executive Director of the Company for a further period of five (5) years , Re-appointment of Mrs. Ritaben Nileshbhai Kikani (DI

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Indo US Bio-Tech Ltd ₹235.00(+18.95/8.77%)	235.00	+18.95	471.22	113.64	47.96	8.65
MPIL Corporation Ltd ₹940.00(-9.90/-1.04%)	940.00	-9.90	53.58	252.06	81.17	3.47
Jaykay Enterprises Ltd ₹138.45(-4.60/-3.22%)	138.45	-4.60	809.35	169.62	137.08	5.65
Modi Rubber Ltd ₹103.50(+3.00/2.99%)	103.50	+3.00	259.16	72.21	11.75	0.68
FGP Ltd ₹7.60(-0.39/-4.88%)	7.60	-0.39	9.04	42.06	0.00	2.83
TCI Industries Ltd ₹1,300.00(0.00/0.00%)	1,300.00	+0.00	117.00	7.26	0.00	12.68

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	22.11	15.81	19.14	18.11	15.50	13.75
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	22.11	15.81	19.14	18.11	15.50	13.75
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.08	0.00	0.03	0.02	0.00	0.00
Total Income	22.19	15.82	19.17	18.13	15.51	13.75
Total Expenditure	17.87	13.22	16.15	15.45	13.45	11.76
PBIDT	4.32	2.60	3.02	2.68	2.06	1.99
Interest	0.37	0.41	0.37	0.28	0.41	0.22
PBDT	3.94	2.19	2.65	2.39	1.65	1.76
Depreciation	0.19	0.21	0.20	0.26	0.29	0.17
Tax	0.09	0.35	0.12	0.08	-0.02	0.30
Deferred Tax	-0.02	-0.04	-0.04	-0.04	0.00	0.00
Reported Profit After Tax	3.68	1.67	2.37	2.10	1.37	1.30
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	3.68	1.67	2.37	2.10	1.37	1.30

EPS (Unit Curr.)	1.84	0.83	2.37	2.09	1.37	1.29
EPS (Adj) (Unit Curr.)	1.84	0.83	1.19	1.05	0.69	0.65
Calculated EPS (Unit Curr.)	1.84	0.83	2.37	2.09	0.68	1.30
Calculated EPS (Adj) (Unit Curr.)	1.84	0.83	1.19	1.05	0.34	0.65
Calculated EPS (Ann.) (Unit Curr.)	7.35	3.33	9.47	8.38	2.74	5.18
Calculated EPS (Adj) (Ann.) (Unit Curr.)	7.35	3.33	4.74	4.19	1.37	2.59
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	20.05	20.05	10.03	10.03	20.05	10.03
Reserve & Surplus	42.17	38.49	46.84	44.47	34.18	40.32
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	19.54	16.45	15.78	14.80	13.29	14.47
PBDTM(%)	17.82	13.85	13.85	13.20	10.65	12.80
PATM(%)	16.64	10.56	12.38	11.60	8.84	9.45

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	10.03	9.17	6.07	6.07	4.85	3.42
Reserves Total	44.47	29.71	15.47	10.37	9.05	1.52
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	54.50	38.88	21.54	16.44	13.90	4.94
Secured Loans	2.46	4.12	2.51	0.08	0.00	0.00
Unsecured Loans	9.14	8.38	8.97	8.50	6.17	6.54
Total Debt	11.60	12.50	11.48	8.58	6.17	6.54
Total Liabilities	66.10	51.38	33.02	25.02	20.07	11.48
APPLICATION OF FUNDS :
Gross Block	7.37	5.54	2.33	2.82	2.58	2.52
Less : Accumulated Depreciation	0.00	0.00	0.00	1.42	1.21	1.02
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	7.37	5.54	2.33	1.40	1.37	1.50
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	1.37	2.32	1.99	1.28	1.17	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.01	0.01	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	26.91	23.36	11.88	9.15	10.71	6.20
Sundry Debtors	24.74	20.54	24.69	20.98	9.06	8.99
Cash and Bank	0.19	0.05	0.13	0.20	0.08	0.07
Loans and Advances	8.07	3.11	1.43	1.58	1.36	0.01
Total Current Assets	59.91	47.06	38.13	31.90	21.21	15.27
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	2.30	3.00	9.77	8.55	2.56	4.67
Provisions	0.10	0.10	0.08	0.40	0.61	0.57
Total Current Liabilities	2.40	3.10	9.85	8.95	3.17	5.25
Net Current Assets	57.52	43.96	28.28	22.95	18.05	10.02
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.63	0.52	0.32	0.00	0.01	0.30
Deferred Tax Liability	0.05	0.11	0.06	0.07	0.00	0.00
Net Deferred Tax	0.58	0.41	0.26	-0.07	0.01	0.30
Total Assets	66.83	52.24	32.87	25.56	20.60	11.82
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.05	0.13	0.20	0.08	0.07
Net Cash from Operating Activities	0.53	2.91	0.22	-0.84	-3.17
Net Cash Used In Investing Activities	-6.67	-5.40	-1.75	-0.57	-2.56
Net Cash Used In Financing Activities	6.29	2.41	1.46	1.53	5.74
Net Inc./Dec In Cash And Cash Equivalents	0.14	-0.08	-0.07	0.12	0.01
Cash And Cash Equivalents At End Of The Year	0.19	0.05	0.13	0.20	0.08

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

70.17%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

29.83%

**Promoter pledged shareholding 70.17%

About Indo US Bio-Tech Ltd

Indo US Bio-Tech Ltd is in the Miscellaneous sector, having a market capitalization of Rs. 471.22 crores. It has reported a sales of Rs. 22.11 crores and a net profit of Rs. 3.68 crores for the quarter ended December 2018. The company management includes Jagdish Ajudia, Jagdish Ajudia,Maltiben Ajudia,Priyanka Ajudia,Ritaben Nileshbhai Kikani,Dimpy Joshi (Indo US Bio-Tech Ltd) among others.

Chairman

Jagdish Ajudia

Registered office

309 Shanti Mall,Satadhar Char Rasta Sola Road,Ahmedabad,Gujarat,380061

FAX :

Background

Incorporation Year2004

Face Value₹10

Market Lot2000

How to buy Indo US Bio-Tech shares on nse?

To buy Indo US Bio-Tech shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Indo US Bio-Tech share price today?

The Indo US Bio-Tech shares price on nse is Rs.235 today.

What is the market cap of Indo US Bio-Tech shares on BSE ?

The company has a market capitalization of Rs.471.22Cr

What is the PE & PB ratio of Indo US Bio-Tech shares ?

PE is 47.96 and PB is 8.65

What is the 52 Week High and Low of Indo US Bio-Tech shares?

Indo US Bio-Tech stock price high: Rs.303.95 Indo US Bio-Tech stock price low: Rs.90.1